ask="4.36"
ask_size="20000"
average_daily_volume="212062"
bid="4.15"
bid_size="300"
book_value="0.74"
change="-0.09"
change_from_200_day_moving_average="1.33"
change_from_50_day_moving_average="0.93"
change_from_52_week_high="-0.55"
change_From_52_week_low="2.73"
change_in_percent="-2.10%"
close="4.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.37"
high_52_weeks="4.75"
last_trade_date="3/3/2017"
last_trade_price="4.20"
last_trade_size="1427"
last_trade_time="4:00pm"
low="4.08"
low_52_weeks="1.47"
market_capitalization="143.42M"
moving_average_200_day="2.87"
moving_average_50_day="3.27"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="4.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+46.22%"
percent_change_from_50_day_moving_average="+28.50%"
percent_change_from_52_week_high="-11.58%"
percent_change_from_52_week_low="+185.71%"
previous_close="4.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.77"
price_per_sales="32.91"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.19"
stock_exchange="NGM"
symbol="FATE"
volume="262244"
weeks_range_52="1.47 - 4.75"
